Suppr超能文献

相似文献

2
Analysis of Chinese Herbal Formulae Recommended for COVID-19 in Different Schemes in China: A Data Mining Approach.
Comb Chem High Throughput Screen. 2021;24(7):957-967. doi: 10.2174/1386207323666201001114101.
3
Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
Front Med. 2020 Dec;14(6):760-775. doi: 10.1007/s11684-020-0803-8. Epub 2020 Sep 14.
7
Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas.
J Ethnopharmacol. 2020 Apr 24;252:112635. doi: 10.1016/j.jep.2020.112635. Epub 2020 Jan 28.
10
Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.
Phytomedicine. 2021 Jan;80:153337. doi: 10.1016/j.phymed.2020.153337. Epub 2020 Sep 28.

引用本文的文献

1
Rapid identification of medicinal plants via visual feature-based deep learning.
Plant Methods. 2024 May 31;20(1):81. doi: 10.1186/s13007-024-01202-6.
2
Exploring the mechanism of agarwood moxa smoke in treating sleep disorders based on GC-MS and network pharmacology.
Front Med (Lausanne). 2024 May 9;11:1400334. doi: 10.3389/fmed.2024.1400334. eCollection 2024.
3
Study on the Nanoaggregate Formation Mechanism and Antipyretic Effect of Maxing Shigan Decoction.
ACS Omega. 2024 Apr 16;9(17):19311-19319. doi: 10.1021/acsomega.4c00423. eCollection 2024 Apr 30.
4
Therapeutic potential of traditional Chinese medicine on heat stroke.
Front Pharmacol. 2023 Sep 25;14:1228943. doi: 10.3389/fphar.2023.1228943. eCollection 2023.
5
Nursing and Treatment Experience of COVID-19 with Facial Paralysis.
SAGE Open Nurs. 2023 Sep 8;9:23779608231196845. doi: 10.1177/23779608231196845. eCollection 2023 Jan-Dec.
6
Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine.
Acta Pharm Sin B. 2023 Jun 5;13(9):3598-637. doi: 10.1016/j.apsb.2023.06.001.
7
Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine.
Clin Complement Med Pharmacol. 2023 Sep;3(3):100089. doi: 10.1016/j.ccmp.2023.100089. Epub 2023 Apr 6.
9
Machine Learning Applications in Drug Repurposing.
Interdiscip Sci. 2022 Mar;14(1):15-21. doi: 10.1007/s12539-021-00487-8. Epub 2022 Jan 23.

本文引用的文献

1
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
2
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
3
Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
J Med Virol. 2020 Sep;92(9):1475-1483. doi: 10.1002/jmv.25961. Epub 2020 May 12.
4
The proximal origin of SARS-CoV-2.
Nat Med. 2020 Apr;26(4):450-452. doi: 10.1038/s41591-020-0820-9.
5
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
7
Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2).
Pharmacol Res. 2020 Jun;156:104761. doi: 10.1016/j.phrs.2020.104761. Epub 2020 Mar 20.
8
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
9
Treatment for severe acute respiratory distress syndrome from COVID-19.
Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20.
10
Clinical features and treatment of COVID-19 patients in northeast Chongqing.
J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验